Clinical evaluation and management of lead-exposed construction workers

American Journal of Industrial Medicine

Volumn 37, Issue 1, 2000, Pages 23-43

  Levin, Stephen M ^a   Goldberg, Mark ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Construction; Epidemiology; Intervention; Lead toxicity; Medical monitoring; Prevent ion; Risk factors; Surveillance; Treatment

Indexed keywords

EDETATE CALCIUM DISODIUM; ERYTHROCYTE PROTOPORPHYRIN; LEAD; PROTOPORPHYRIN ZINC; SUCCIMER;

BUILDING INDUSTRY; HUMAN; INDUSTRIAL HYGIENE; LEAD POISONING; MEDICAL EXAMINATION; OCCUPATIONAL DISEASE; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TOXICOKINETICS;

ABSORPTION; CONSTRUCTION MATERIALS; HEALTH EDUCATION; HUMANS; LEAD; LEAD POISONING; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK FACTORS; TISSUE DISTRIBUTION; UNITED STATES; UNITED STATES OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION;

EID: 0033991485     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0274(200001)37:1<23::AID-AJIM4>3.0.CO;2-U     Document Type: Review

References (140)

1. al-Saleh IA. 1995. Lead exposure in Saudi Arabia and its relationship to smoking. Biometals 8:243-245.
2. Anttila A, Sallmén M. 1995. Effects of parental occupational exposure to lead and other metals on spontaneous abortion. J Occup Environ Med 37:915-921.
3. Aposhian MM, Maiorino RM, Xu Z, Aposhian HV. 1996. Sodium 2,3-, imercapto-1-propanesulfonic acid (DMPS) treatment does not redistribute lead or mercury to the brain of rat. Toxicology 109:45-55.
4. Araki S, Honma T, Yanagihara S, Ushio K. 1980. Recovery of slowed nerve conduction velocity in lead-exposed workers. Int Arch Occ Environ Health 46:151-157.
5. Assennato G, Paci C, Baser ME, Molinini R, Candela RG, Altamura BM, Giorgino R. 1987. Sperm count suppression without endocrine dysfunction in lead-exposed men. Arch Environ Health 42:124-127.
6. Astrin KH, Bishop DF, Wetmur JG, Kaul BC, Davidow B, Desnick RJ. 1987. ∂-aminolevulinic acid dehydratase isoenzymes and lead toxicity. Ann NY Acad Sci 514:23-29.
7. ATSDR (Agency for Toxic Substances and Disease Registry). 1990. Toxicological profile for lead. Atlanta p 27.
8. ATSDR (Agency for Toxic Substances and Disease Registry). 1998. Toxicological profile for lead (update). Atlanta, p 346.
9. Aviv A, John E, Bernstein J, Goldsmith DI, Spitzer A. 1980. Lead intoxication during development: its late effects on kidney function and blood pressure. Kidney Int 17:430-437.
10. Baker EL, Feldman RG, White RF, Harley JP. 1983. The role of occupational lead exposure in the genesis of psychiatric and behavioral disturbances. Acta Psychiatr Scand Suppl 67:38-48.
11. Baker EL Jr, Goyer RA, Fowler BA, Khettry U, Bernard DB, Adler S, White RD, Babayan R, Feldman RG. 1980. Occupational lead exposure, nephropathy and renal cancer. Am J Ind Med 1:139-148.
12. Balbus-Kornfeld JM, Stewart W, Bolla KI, Schwartz BS. 1995. Cumulative exposure to inorganic lead and neurobehavioral test performance in adults: an epidemiological review. Occup Environ Med 52:2-12.
13. Barry PS. 1975. A comparison of concentrations of lead in human tissues. Br J Ind Med 32:119-139.
14. Beaver DL. 1961. The ultrastructure of the kidney in lead intoxication with particular reference to intranuclear inclusions. Am J Path 39:195-202.
15. Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. 1987. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. NEJM 316:1037-1043.
16. Bergdahl IA, Gerhardsson L, Schutz A, Desnick RJ, Wetmur JG, Skerfving S. 1997. Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Arch Environ Health 52:91-96.
17. Bergdahl IA, Stromberg U, Gerhardsson L, Schutz A, Chettle DR, Skervfing S. 1998. Lead concentrations in tibial and calcaneal bone in relation to the history of occupational lead exposure. Scand J Work Environ Health 24:38-45.
18. Bornschein RL, Hammond PB, Dietrich KN, Succop N, Drafft K, Clark S, Berger O, Pearson D, Que Hee S. 1985. The Cincinnati prospective study of low-level lead exposure and its effects on child development: protocol and status report. Environ Res 38:4-18.
19. Boscolo P, Carmignani M. 1988. Neurohumoral blood pressure regulation in lead exposure. Environ Health Perspect 78:101-106.
20. Braunstein GD, Dahlgren J, Loriaux DL. 1978. Hypogonadism in chronically lead-poisoned men. Infertility 1:33-51.
21. Brody DJ, Pirkle J, Kramer RA, Flegal KN, Matte TD, Genter E, Paschal DE. 1994. Blood lead levels in the U.S. population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1991). JAMA 272(4):277-183.
22. Campbell BC, Baird AW. 1977. Lead poisoning in a group of demolition workers. Br J Ind Med 34:298-304.
23. CDC. 1989. Lead poisoning in bridge demolition workers - Massachusetts. MMWR 38:687-694.
24. CDC. 1992a. Elevated blood lead levels in adults - United States, second quarter, 1992. MMWR 41(38):715-716.
25. CDC. 1992b. Lead exposure among lead burners - Utah. MMWR 41:307-310.
26. CDC. 1993. Lead poisoning in bridge demolition workers - Georgia, 1992. MMWR 42:388-390.
27. CDC. 1999. Adult blood lead epidemiology and surveillance - United States, second and third quarters, 1998, and Annual 1994-1997. MMWR 48(10):213-216.
28. Chang HR, Chen SS, Tsao DA, Cheng JT, Ho CK, Yu HS. 1997. Reduced vascular beta-adrenergic receptors and catecholamine response in rats with lead induced hypertension. Arch Toxicol 71: 778-781.
29. Chia KS, Jeyaratman J, Tan C, Ong HY, Ong CN, Lee E. 1995. Glomerular function of lead-exposed workers. Toxicol Letters 77:319-328.
30. Chia KS, Mutti A, Tan C, Ong HY, Jeyarataram J, Ong CN, Lee E. 1994. Urinary N-acetyl-β-D-glucosaminidase activity in workers exposed to inorganic lead. Occup Environ Med 41:256-259.
31. Chisolm, JJ Jr. 1981. Dose-effect relationships for lead in young children: evidence in children for interactions among lead, zinc, and iron. In: Lynam DR, Piantanida LG, Cole JF, editors. International Symposium on Environmental Lead Research, 2nd ed. New York: Academic Press.
32. Cooper WC. 1985. Mortality among employees of lead battery plants and lead-producing plants, 1947-1980. Scand J Work Environ Health 11:331-345.
33. Cullen MR, Kayne RD, Robins JM. 1984. Endocrine and reproductive dysfunction in men associated with occupational inorganic lead intoxication. Arch Environ Health 39:431-440.
34. Cullen MR, Robins JM, Eskenazi B. 1983. Adult inorganic lead intoxication: presentation of 31 new cases and a review of recent advances in the literature. Medicine (Baltimore) 62: 221-247.
35. Czachur M, Stanbury M, Gerwel B, Gochfeld M, Rhoads GG, Wartenberg D. 1995. A pilot study of take-home lead exposure in New Jersey. Am J Ind Med 28:289-293.
36. de Kort WL, Verschoor MA, Wibowo AA, van Hemmen JJ. 1987. Occupational exposure to lead and blood pressure: a study in 105 workers. Am J Ind Med 22(2):145-156.
37. Domingo JL, Paternain JL, Llobet JM, Corbella J. 1988. Developmental toxicity of subcutaneously administered meso-2,3-dimercaptosuccinic acid in mice. Fund Appl Toxicol 11:715-722.
38. dos Santos AC, Colacciopo S, Dal Bo CMR, dos Santos NAG. 1994. Occupational exposure to lead, kidney function tests and blood pressure. Am J Ind Med 26(5):635-643.
39. Dumas P, Gueldry D, Loireau A, Chomard P, Buthieau AM, Autissier N. 1985. Effects of lead poisoning on properties of brain mitochondria in young rats. C R Soc Biol 179:175-183.
40. Eisinger JE, Blumberg WE, Fischbein A. 1978. Zinc protoporphyrin in blood as a biological indicator of chronic lead intoxication. J Environ Pathol Toxicol 1:897-910.
41. Environmental lead. Proceedings of the Second International Symposium on Environmental Lead Research; December, 1978; Cincinnati, Ohio, New York, NY: Academic Press, p 1-7.
42. Far HS, Pin NT, Kong CY, Fong KJS, Kian CW, Yan CK. 1993. An evaluation of the significance of mouth and hand contamination for lead absorption in lead-acid battery workers. Int Arch Occup Environ Health 64:439-443.
43. Fischbein A. 1998. Occupational and environmental exposure to lead. In: Rom W, editor. Environmental and occupational medicine. 3rd ed. Philadelphia: Lippincott-Raven, p 973-996.
44. Fischbein A, Campbell C, Luo JC, 1992. Low level and bystander exposure to lead among factory workers. NY State J Med 92: 525-528.
45. Fischbein A, Leeds M, Solomon S. 1984. Lead exposure among iron workers in New York city: a continuing occupational hazard in the 1980s. NY State J Med 84:445-448.
46. Fleet JC. 1996. Bone lead as a risk factor for hypertension in men. Nutr Rev 54(6):180-182.
47. Flegal AR, Smith DR. 1992. Lead levels in preindustrial humans (letter). NEJM 326:1293-1294.
48. Fowler BA, Kahng MS, Smith DR. 1994. Role of lead-binding proteins in renal cancer. Env Health Perspect (102 Suppl.) 3:115-116.
49. Fu H, Boffetta P. 1995. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med 52:73-81.
50. Fullerton PM. 1966. Chronic peripheral neuropathy produced by lead poisoning in guinea pigs. J Neuropathol Exp Neurol 25: 214-236.
51. Gennart JP, Buchet JP, Roels H, Ghyselen P, Ceulemans E, Lauwerys R. 1992. Fertility of male workers exposed to cadmium, lead, or manganese. Am J Epid 135:1208-1219.
52. Goldman RH, White R, Kales SN, Hu H. 1994. Lead poisoning from mobilization of bone stores during thyrotoxicosis. Am J Ind Med 25:417-424.
53. Gong Z, Evans HL. 1997. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat. Toxicol Appl Pharmacol 144:205-214.
54. Gonzalez-Cossio T, Peterson KE, Sanin LH, Fishbein E, Palazuelos E, Aro A, Hernandez-Avila M, Hu H. 1997. Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics 100:865-862.
55. Goyer RA, Krall A, Kimball JP. 1968. The renal tubule in lead poisoning. II. In vitro studies of mitochondrial structure and function. Lab Investigation 19(1):78-83.
56. Goyer RA. 1971. Lead and the kidney. Current Topics Pathol 55:147-176.
57. Grandjean P, Jacobsen IA, Jorgensen PJ. 1991. Chronic lead poisoning treated with dimercaptosuccinic acid. Pharmacol Toxicol 68:266-269.
58. Graziano JH. 1986. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol 1:155-162.
59. Hall A, Cantab MD. 1905. The increasing use of lead as an abortifacient: a series of thirty cases of plumbism. Br Med J 1: 584-587.
60. Hanninen H, Aitio A, Kovala T, Luukkonen R, Matikainen E, Mannelin T, Erkkilä J, Riihimäki V. 1998. Occupational exposure to lead and neuropsychological dysfunction. Occup Environ Med 55:202-209.
61. Harlan WR, Landis JR, Schmouder RL, Goldstein NG, Harlan LC. 1985. blood lead and blood pressure. Relationship in the adolescent and adult US population. JAMA 253:530-534.
62. Hartwig A. 1994. Role of DNA repair inhibition in lead-and cadmium-induced genotoxicity: a review. Environ Health Perspect (102 Suppl.) 3:45-50.
63. Henderson DA. 1958. The aetiology of chronic nephritis in Queensland. Med J Aust 1:377-386.
64. Hu H. 1991. A 50-year follow-up of childhood plumbism. Hypertension, renal function, and hemoglobin levels among survivors. Am J Dis Child 145(6):681-687.
65. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, Rotnitzky A. 1996. The relationship of bone and blood lead to hypertension. The normative aging study. JAMA 275:1171-1176.
66. Hu H, Milder FL, Burger DE. 1990. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposure. Arch Environ Health 45:335-341.
67. Hu H, Watanabe H, Payton M, Korrick S, Rotnitzky A. 1994. The relationship between bone lead and hemoglobin. JAMA 272: 1512-1517.
68. Hu WY, Wu SH, Wang LL, Wang GI, Fan H, Liu ZM. 1992. A toxicological and epidemiological study on reproductive functions of male workers exposed to lead. J Hyg Epidemiol Microbiol Immunol 36:25-30.
69. IARC (International Agency for Research on Cancer). 1987. Overall evaluation of carcinogenicity: an updating of IARC Monographs Vol 1 to 42. IARC Monogr Eval Carcinog Risks Hum; update 1-42:230-232.
70. Johnson BL, Burg JR, Xintaras C, Handke JL. 1980. A neurobehavioral examination of workers from a primary nonferrous smelter. Neurotox 1:561-581.
71. Kajiyama K, Doi R, Sawada J, Hashimoto K, Hazama T, Nakata S, Hirata M, Yoshida T, Miyajima K. 1993. Significance of subclinical entrapment of nerves in lead neuropathy. Environ Res 60:248-253.
72. Kala SV, Jadhav AL. 1995. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. Neurotox 16:297-308.
73. Karita K, Shinozaki T, Tomita K, Yano E. 1997. Possible oral lead intake via contaminated facial skin, Sci Total Environ 199:125-131.
74. Keogh JP, Gordon J. 1994. Occupational lead poisoning: who should conduct surveillance and training? Am J Ind Med 26(5):713-715.
75. Kim R, Rotnitsky A, Sparrow D, Weiss S, Wager C, Hu H. 1996. A longitudinal study of low-level lead exposure and impairment of renal function. JAMA 275:1177-1181.
76. Kovala T, Matikainen E, Mannelin T, Erkkila J, Riihimaki V, Hanninen H, Aitio A. 1997. Effects of low level exposure to lead on neurophysiological functions among lead battery workers. Occup Environ Med 54:487-493.
77. Kumar BD, Krishnaswamy K. 1995. Detection of occupational lead nephropathy using early renal markers. J Toxicol Clin Toxicol 33:331-335.
78. Lancranjan I, Popescu HI, Gavenuscu O, Klepsch I, Serbaniscu M. 1975. Reproductive ability of workers occupationally exposed to lead. Arch Environ Health 30:396-401.
79. Landrigan PJ, Baker EL, Himmelstein JS, Stein GF, Wedding JP, Straub WE. 1982. Exposure to lead from the Mystic River Bridge: the dilemma of deleading. N Eng J Med 306:673-676.
80. Landrigan PJ, Silbergeld E, Froines JR, Pfeffer RM. 1990. Lead in the modern workplace (Editorial). Am J Public Health 80:907-908.
81. Lauwerys R, Bernard A. 1989. Preclinical detection of nephrotoxicity: description of the tests and appraisal of their health significance. Toxicol Letters 46:13-29.
82. Legge TM. 1901. Industrial lead poisoning. J Hyg 1:96-108.
83. Legge TM, Goadby KW. 1912. Lead poisoning and lead absorption. London: Arnold.
84. Levin SM, Goldberg M, Doucette JT. 1997. The effect of the OSHA lead in construction standard on blood lead levels among iron workers employed in bridge rehabilitation. Am J Ind Med 31:303-309.
85. Lilis R. 1981. Long term occupational lead exposure, chronic nephropathy, and renal cancer: a case report. Am J Ind Med 2: 293-297.
86. Lilis R, Fischbein A, Eisinger J, Blumberg WE, Diamond S, Anderson HA, Rom W, Rice C, Sarkozi L, Kon S, Selikoff IJ. 1977. Prevalence of lead disease among secondary lead smelter workers and biological indicators of lead exposures. Environ Res 14:255-285.
87. Lilis R, Fischbein A, Valciukas JA, Blumberg W, Selikoff IJ. 1980. Kidney function and lead: relationships in several occupational groups with different levels of exposure. Am J Ind Med 1:405-412.
88. Lilis R, Gavrilescu N, Nestorescu B, Dumitriu C, Roventa A. 1968. Nephropathy in chronic lead poisoning. Br J Ind Med 25: 196-202.
89. Lilis R, Landrigan PJ. 1988. Renal and urinary tract disorders. In: Levy BS, Wegman DH, editors. Occupational health: recognizing and preventing work-related illness. 2nd ed. Boston: Little, Brown & Co. p 465-476.
90. Lin JL, Ho HH, Yu CC. 1999. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial. Ann Intern Med 130:7-13.
91. Lin S, Hwang SA, Marshall EG, Stone R, Chen J. 1996. Fertility rates among lead workers and professional bus drivers: a comparative study. Ann Epidemiol 6(3):201-208.
92. Lindbohm ML, Sallmen M, Anttila A, Taskinen H, Hemminki K. 1991. Paternal occupational lead exposure and spontaneous abortion. Scan J Work Environ Health 17:95-103.
93. ++-EDTA chelation for mild lead intoxication. JOM 34:638-641.
94. Loghman-Adham M. 1997. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 105:928-939.
95. Maheswaran R, Gill JS, Beevers DG. 1993. Blood pressure and industrial lead exposure. Am J Epidemiol 137(6):645-653.
96. Manton WI. 1985. Total contribution of airborne lead to blood lead. Br J Ind Med 42:168-172.
97. Marino PE, Franzblau A, Lilis R, Landrigan PJ. 1989. Acute lead poisoning in construction workers: the failure of current protective standards. Arch Environ Health 44:140-145.
98. Muldoon SB, Cauley JA, Kuller LH, Morrow L, Needleman HL, Scott J, Hooper FJ. 1996. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology 15:62-72.
99. Mutti A. 1989. Detection of renal diseases in humans: developing markers and methods. Toxicol Letters 46:177-191.
100. NYS DOT, Lead Health & Safety Program, Engineering Instruction 95-014, March 13, 1995.
101. Nilsson U, Attewell R, Christoffersson JO, Schutz A, Ahlgren L, Skerfving S, Mattsson S. 1991. Kinetics of lead in bone and blood after end of occupational exposure. Pharmacol Toxicol 68:477-484.
102. Oliver Sir T. 1914. Lead poisoning: from the industrial, medical and social points of view. (Lectures delivered at the Royal Institute of Public Health) New York: Hoeber.
103. Osorio AM, Melius J. 1995. Lead poisoning in construction. In: Ringen K, Englund A, Welch L, Weeks J, Seegal J, editors. Construction safety and health. Occ Med State of the Art Rev 10:353-361.
104. Parkinson DK, Hodgson MJ, Bromet EJ, Dew MA, Connell MM. 1987. Occupational lead exposure and blood pressure. Br J Ind Med 44(11):744-748.
105. Piacitelli GM, Whelan EA, Sieber WK, Gerwel B. 1997. Elevated lead contamination in homes of construction workers. Am Ind Hyg Assoc J 58:447-454.
106. Piomelli S, Corash L, Corash MB. 1980. Blood lead concentrations in a remote Himalayan population. Science 210:1135-1137.
107. Rabin R, Davis L, Brooks D. 1992. Lead at work: elevated blood lead levels in Massachusetts. April-October 1991. Boston; Occupational Lead Registry, Division of Occupational Hygiene, Massachusetts Department of Labor and Industries, and Occupational Health Surveillance Program, Bureau of Statistics, Research and Evaluation, Massachusetts Department of Public Health.
108. Rabinowitz MB, Wetherill GW, Kopple JD. 1976. Kinetic analysis of lead metabolism in healthy humans. J Clin Investigation 58:260-270.
109. Repko JD, Corum CR, Jones PD, Garcia LS Jr. 1978. The effects of inorganic lead on behavioral and neurologic function. Cincinnati, OH; U.S. Department of Health; DHEW (NIOSH) publication no. 78-128, 92 p.
110. Reynolds PP, Knapp MJ, Baraf HS, Holmes EW. 1983. Moonshine and lead. Arthritis Rheum 11:1057-1064.
111. Rosen JF. 1989. Metabolic abnormalities in lead toxic children: public health implications. Bull NY Acad Med 65:1067-1083.
112. Schuhmacher M, Bosque MA, Domingo JL, Corbella J. 1994. Effects of chronic lead and cadmium exposure on blood pressure in occupationally exposed workers. Biol Trace Elem Res 41(3): 269-278.
113. Schutz A, Skerfving S. 1976. Effects of a short, heavy exposure to lead dust upon blood lead level, erythrocyte ∂-aminolevulinic acid dehydratase activity and urinary excretion of lead, ∂-aminolevulinic acid, and coproporphyrin: results of a 6-month follow-up of two male subjects. Scand J Work Environ Health 2:176-184.
114. Schwartz J. 1995. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health 50(1):31-37.
115. Selevan SG, Landrigan PJ, Stern FB, Jones JH. 1985. Mortality of lead smelter workers. Am J Epidemiol 122:673-683.
116. Seppalainen AM, Hernberg S, Vesanto R, Kock B. 1983. Early neurotoxic effects of occupational lead exposure: a prospective study. Neurotoxicology 4:181-192.
117. Silbergeld EK, Schwartz J, Mehaffey K. 1988. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 47:79-94.
118. Skerfving S, Nilsson U, Schutz A, Gerhardsson L. 1993. Biological monitoring of inorganic lead. Scand J Work Environ Health (19 Suppl.) 1:59-64.
119. Skoczynska A, Juzwa W, Smolik R, Szechinski J, Behal FJ. 1986. Response of the cardiocascular system to catecholamines in rats given small doses of lead. Toxicology 39(3):275-289.
120. Smith CM, Wang X, Hu H, Kelsey KT. 1995. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 103(3):248-253.
121. Staessen J. 1995. Low-level lead exposure, renal function and blood pressure. Verh K Acad Geneerkd Belg 57:527-574.
122. Staessen JA, Lauwerys RR, Bucher J-P, Bulpitt CJ, Rondia D, Vanrenterghem Y, Amery A. 1992. Impairment of renal function with increasing blood Pb concentration in the general population. NEJM 327:151-156.
123. Stollery BT, Banks HA, Broadbent DE, Lee WR. 1989. Cognitive functioning in lead workers. Br J Ind Med 46(10):698-707.
124. Tepper LB. 1963. Renal function subsequent to childhood lead plumbism. Arch Environ Health 7:76-85.
125. Todd AC, McNeil FE, Fowler BA. 1992. In vivo x-ray fluorescence of lead in bone. Environ Res 59:326-335.
126. Todd AC, Wetmur JG, Moline JM, Godbold JH, Levin SM, Landrigan PJ. 1996. Unraveling the chronic toxicity of lead: an essential priority for environmental health. Environ Health Perspect 104(Suppl 1): 141-146.
127. U.S. Department of Labor, Occupational Safety and Health Administration, 29 CFR Part 1926: Lead Exposure in Construction; Interim Final Rule. 1993. Fed Reg, Vol. 58, No 84-Tuesday, May 4, 1993.
128. U.S. Department of Labor, Occupational Safety and Health Administration, Occupational Exposure to Lead. 1978. Fed Reg, Vol. 43, No 220-Tuesday, Nov. 14, 1978.
129. U.S. Environmental Protection Agency. 1986. Air quality criteria for lead. Vol IV. EPA/600/8-83/028dF.
130. Valciukas JA, Lilis R, Eisinger J, Blumberg WE, Fischbein A, Selikoff IJ. 1978. Behavioral indicators of lead neurotoxicology: results of a clinical field survey. Int Arch Occup Environ Health 41:217-236.
131. Vander AJ. 1988. Chronic effects of lead on the renin-angiotensin system. Environ Health Perspec 78:77-83.
132. Verschoor M, Wibowo A, Herber R, van Hemmen J, Zielhuis R. 1987. Influence of occupational low-level lead exposure on renal parameters. Am J Ind Med 12(4):341-351.
133. Victery W. 1988. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ Health Perspect 78:71-76.
134. Waalkes MP, Diwan BA, Ward JM, Devor DE, Goyer RA. 1995. Renal tubular tumores and atypical hyperplasias in B6C3F1 mice exposed to lead acetate during gestation and lactation occur with minimal chronic nephropathy. Cancer Res 55:5265-5271.
135. Wedeen RP, Maesaka JK, Weiner B, Lipat GA, Lyons MM, Vitale LF, Joselow MM. 1975. Occupational lead nephropathy. Am J Med 59:630-641.
136. Williams MK. 1984. Biological tests of lead absorption following a brief massive exposure. J Occup Med 26:532-533.
137. Wildt K, Berlin M, Isberg PE. 1987. Monitoring of zinc protoporphyrin levels in blood following occupational lead exposure. Am J Ind Med 12:385-398.
138. Wu TN, Shen CY, Ko KN, Guu CF, Gau HJ, Lai JS, Chen CJ, Chang PY. 1996. Occupational lead exposure and blood pressure. Int J Epidemiol 25(4):791-796.
139. Xuezhi J, Youxin L, Yilan W. 1992. Studies of lead exposure on reproductive system: a review of work in China. Biomed Environ Sci 5:266-275.
140. Zimmer, FE. 1961. Lead poisoning in scrap metal workers. JAMA 175:238-240.